Search

Danaher Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

230.4 0.59

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

226.8

Max

230.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-159M

870M

Pardavimai

314M

6.3B

P/E

Sektoriaus vid.

40.005

49.241

Pelnas, tenkantis vienai akcijai

1.94

Dividendų pajamingumas

0.63

Pelno marža

13.887

Darbuotojai

58,000

EBITDA

353M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+10.13% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.63%

2.15%

Kitas dividendų mokėjimo data

2026-10-30

Kita Ex Dividend data

2026-12-25

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

15B

158B

Ankstesnė atidarymo kaina

229.81

Ankstesnė uždarymo kaina

230.4

Danaher Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-23 23:01; UTC

Danaher Corp's shares rose slightly in after-market hours, recovering from an initial low and remaining above its 20-day moving average.

2026-10-22 22:02; UTC

Correlated Moves
News

Danaher Corp reported a revenue miss due to $80M in tariff-related adjustments and raised its full-year adjusted earnings guidance amid a conservative outlook.

2026-10-21 23:36; UTC

Danaher Corp's shares are modestly lower in after-market trading, retracing from a brief peak shortly after the market closed.

2026-10-20 23:02; UTC

Danaher Corp declined during after-market trading, continuing a trend of four consecutive sessions closing lower amid persistent downward pressure.

2026-10-19 20:01; UTC

News
Correlated Moves

Danaher Corporation is set to report third-quarter earnings on October 21, with analysts expecting $1.92 per share and $6.56 billion in revenue.

2026-10-17 00:01; UTC

Danaher Corp is trading higher in after-market hours, reaching its highest cumulative return of the session and significantly above its 20-day moving average.

2026-10-16 23:31; UTC

Danaher Corp shares are trading lower in after-market hours, reflecting a broader market decline amid persistent inflationary pressures indicated by today's economic data.

2026-10-15 21:02; UTC

Danaher Corp shares declined modestly in after-market trading, following a volatile session that saw the stock turn lower after initial gains.

2026-10-14 23:41; UTC

Danaher Corp is trading modestly higher in after-market hours, continuing a trend of five consecutive sessions of gains and remaining above its 20-day moving average.

2026-10-13 23:01; UTC

Danaher Corp is trading modestly higher in after-market hours, maintaining a position well above its 20-day moving average despite notable fluctuations.

2026-10-12 23:26; UTC

News

Danaher Corporation appoints Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to its Board of Directors, expanding it from 11 to 13 members.

2026-10-09 20:06; UTC

Correlated Moves

Danaher Corp shares are advancing, aligning with broader market gains and a rise in the life sciences sector, bolstered by positive developments at Repligen Corp.

2026-10-08 23:01; UTC

Danaher Corp shares declined modestly in after-market hours, falling below Thursday's close amid unusual trading behavior and remaining in the middle of its one-month range.

2026-10-07 23:00; UTC

Danaher Corp's shares traded lower in after-market hours, declining before slightly recovering, while remaining near the middle of their one-month trading range.

2026-10-06 22:21; UTC

Danaher Corp's shares advanced modestly in after-market hours, reflecting broader market gains and positioning above its 20-day moving average.

2026-10-05 23:15; UTC

Danaher Corp's shares are trading modestly lower in after-market hours, down from Monday's close despite a minor recovery earlier in the session.

2026-10-02 20:03; UTC

Danaher Corp is advancing, continuing its upward trend since Thursday's close, despite pulling back from an earlier session high.

2026-10-01 23:35; UTC

Danaher Corp is trading slightly lower in after-market hours, extending a trend of declines over the past four consecutive sessions.

2026-09-30 23:00; UTC

Danaher Corp has advanced in after-market trading, moving significantly higher from a flat start and positioned well above its 20-day moving average.

2026-09-29 20:21; UTC

Danaher Corp is trading modestly lower in after-market hours, declining after an initial uptick, despite being above its 20-day moving average.

2026-09-28 23:01; UTC

Danaher Corp's shares are trading modestly lower in after-market hours, continuing a decline since Monday's close and remaining at their lowest point during this session.

2026-09-26 00:01; UTC

Danaher Corp is declining in after-market trading, moving lower since Friday's close, ending a streak of five consecutive higher sessions.

2026-09-25 20:12; UTC

Danaher Corp is trading modestly lower in after-market hours, maintaining a loss since Friday's close despite being above its 20-day moving average.

2026-09-24 23:01; UTC

Danaher Corp is trading modestly lower in after-market hours, following a notable decline that resulted in a significantly negative cumulative return for the day.

2026-09-23 22:36; UTC

Danaher Corp is lower in after-market trading, showing a slight recovery after a decline earlier in the session, remaining near its one-month range.

2026-09-22 20:07; UTC

Social Media
News

Danaher Corp shares reached a four-week high today, marking the highest price since August 2026, supported by strong online commentary and strategic adjustments.

2026-09-21 22:41; UTC

Danaher Corp's shares declined modestly in after-market trading, reversing an initial uptick, but remain above their 20-day moving average.

2026-09-18 20:06; UTC

Correlated Moves

Danaher Corp shares fell modestly as the market trades lower, influenced by a slight decline in Thermo Fisher Scientific after an early high.

2026-09-17 23:31; UTC

Danaher Corp is experiencing a modest rise in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-09-16 20:10; UTC

News
Correlated Moves

Danaher Corporation's shares are modestly lower despite the launch of research-grade S.p. Cas9 mRNA by its subsidiaries Integrated DNA Technologies and Aldevron.

Akcijų palyginimas

Kainos pokytis

Danaher Corp Prognozė

Kainos tikslas

By TipRanks

10.13% į viršų

12 mėnesių prognozė

Vidutinis 253.857 USD  10.13%

Aukščiausias 275 USD

Žemiausias 200 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Danaher Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

13

Pirkti

1

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat